An announcement from PainChek Ltd ( (AU:PCK) ) is now available.
PainChek Ltd announced the results of its General Meeting, where a resolution was successfully passed. The company continues to enhance its industry positioning with its innovative pain assessment technology, which has been widely adopted in over 1,800 aged care facilities and is undergoing FDA review in the United States. This expansion into home care services and partnerships with disability service providers highlights its commitment to broadening its impact on pain management practices, benefiting stakeholders such as nurses, carers, and healthcare professionals.
More about PainChek Ltd
PainChek Ltd is a company specializing in the development of smartphone-based applications for pain assessment and monitoring. Their primary product, the PainChek app, is a regulatory-cleared medical device that combines AI-driven pain assessment with the Numerical Rating Scale to provide accurate and consistent pain management solutions. The company focuses on improving pain management practices in various environments, including aged care facilities and home care, and has expanded its reach globally with regulatory clearances in multiple countries.
YTD Price Performance: 16.67%
Average Trading Volume: 948,775
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$63.27M
Learn more about PCK stock on TipRanks’ Stock Analysis page.